Impact of reduced dose intensity of adjuvant anthracycline based chemotherapy in a population based cohort of stage I-II breast cancers Conclusions: Doubeling the number of cycles of neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results